Colorectal Liver Metastases Clinical Trials

43 clinical trials for Colorectal Liver Metastases across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• TRANsplantation vs reSECTion After Conversion Therapy for Initially Unresectable Colorectal Liver Metastases — RECRUITING · NA
• Anatomical Resection of liver MetAstases iN patIents with RAS-mutated colorectal cancer — RECRUITING
• Adjuvant FOLFIRI Based-chemotherapy After Resection of CLM Responding to Preoperative FOLFIRI — RECRUITING · PHASE3
• Ivonescimab Plus Chemotherapy in Patients With Initially Unresectable Colorectal Cancer Liver Metastases — RECRUITING · PHASE2
• Paclitaxel Cationic Liposome (Hepatic Arterial Infusion) in Combination With Systemic Therapy as First-Line Treatment in Colorectal Liver Metastases — RECRUITING · PHASE1
• Ablation With Confirmation of Colorectal Liver Metastases (ACCLAIM) — RECRUITING · NA
• COLORS-Validate Study of Decision-Support Software for Surgical Sequencing in Colorectal Liver Metastases — NOT_YET_RECRUITING
• Dual-agent fluorescence-guided surgery for colorectal liver metastases — NOT_YET_RECRUITING · PHASE3
• INJECTABL-II trial: Dose finding, efficacy and immunological response of a novel immuno-adjuvant (IP-001) following microwave ablation or irreversible electroporation for colorectal liver metastases. — TERMINATED · PHASE2
• Extended Criteria Treatment for Liver Metastases With Heavy Tumour Burden — COMPLETED · PHASE2
• PUMP-IT RCT: Hepatic arterial infusion PUMP chemotherapy combined with systemic therapy versus systemic therapy alone as Induction Therapy for initially unresectable colorectal liver metastases: a randomised controlled trial — TERMINATED · PHASE3
• Preoperative immunotherapy with atezolizumab (Tecentriq®) and tiragolumab or atezolizumab (Tecentriq®) and bevacizumab (Avastin®) in patients with colorectal liver metastases (CRLM) (the PURPLE trial) — TERMINATED · PHASE2
• Yttrium-90 Radioembolization Neoadjuvant Therapy With Immune Marker Profiling and Dosimetry for Potentially Resectable Patients With Colorectal Liver Metastases — NOT_YET_RECRUITING
• Integrated Clinical-molecular Risk Stratification to Early Recurrence in Colorectal Liver Metastases — NOT_YET_RECRUITING
• Laparoscopic Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) for Colorectal Liver Metastases (CRLM) — NOT_YET_RECRUITING
• COLLISION RELAPSE trial Recurrent colorectal liver metastases: repeat local treatment +/- neoadjuvant systemic therapy, a phase III prospective randomized controlled trial — TERMINATED · PHASE3
• The Swedish Study of Liver Transplantation for Non-resectable Colorectal Cancer Metastases — ACTIVE_NOT_RECRUITING · NA
• Combining drug-eluting bead chemoembolization and radioembolization for treatment of colorectal liver metastases: DEBIR90Y study — OTHER · PHASE1
• Patient Outcomes After Hepatic Artery Infusion Pump Placement — COMPLETED
• High- and Low-dose Radiotherapy Combined With PD-1 Inhibitors for MSS CRLM — OTHER · PHASE1
• To Evaluate the Performance of HepaSphere Transarterial Chemoembolization Combined With Hepatic Arterial Infusion Chemotherapy on Unresectable Colorectal Liver Metastases — OTHER
• The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases — OTHER · PHASE2
• Pilot-study: Non-thermal Ablation Using Irreversible Electroporation to Treat Colorectal Liver Metastases — COMPLETED · PHASE1
• Efficacy of Irreversible Electroporation (IRE) for Central Colorectal Liver Metastases — COMPLETED · PHASE2
• Colorectal Metastasis and Liver Transplantation With Organs From Deceased Donors — OTHER · NA
• The Role of Tumor-associated Macrophages in Colorectal Liver Metastases — COMPLETED
• Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases — COMPLETED
• Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases — COMPLETED · PHASE1
• Intratumoral CD3+ and NKp46+ Cells in Colorectal Liver Metastases — COMPLETED
• Comparison of Primovist-enhanced MRI, Diffusion Weighted MRI and Multidetector CT of Colorectal Liver Metastases — COMPLETED · NA
• Multiple Minor Hepatectomies Versus Major or Extended Hepatectomies for Colorectal Liver Metastases. — COMPLETED
• Prevention of the Hepatic Sinusoidal Obstruction Syndrome by Means of Anticoagulants — COMPLETED
• The Effect of Fish Oils on Human Hepatic Colorectal Metastases — COMPLETED · PHASE2
• CyberKnife® for Hepatic Metastases From Colorectal Cancer — TERMINATED · PHASE2
• Folfox-B Study for Patients With Colorectal Liver Metastases — TERMINATED · PHASE2
• Optimised Recovery With Accelerated Nutrition and GI Enhancement — COMPLETED · NA
• Effect of Neoadjuvant Radiation on Tumor Infiltrating T-cells by Low Dose Radiation in Colorectal Liver Metastases — OTHER · PHASE1
• Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression — OTHER
• Impact of Preoperative Chemotherapy on Complications and Regeneration After Resection of Colorectal Liver Metastases — COMPLETED
• Alternative Surgical Policy for Central Liver Tumors — COMPLETED
• Preoperative Hepatic Arterial Infusion Chemotherapy — OTHER
• Quality of Life and Liver Metastases — COMPLETED
• Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases — COMPLETED · PHASE3

Refine this search